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Cedex, France), F. Simondon, W. Saurin, and H. Sarmini. A simple model relevant 
to toxoplasmosis applied to epidemiologic results in France. Am J €pidemio/ 
A simple mathematical model was applied to the results of a seroepidemiologic 
study of toxoplasmosis carried out in France in 1982-1983. An adequate fitting 
to the prevalence data observed on 7,605 women of childbearing age was 
obtained. Thus, the data were used to estimate the seroconversion rate, allowing 
the approach to and discussion of insights gained from the model, such as the 
risk of Toxoplasma infection during pregnancy, the age-related expected risks of 
maternal seroconversion, as well as an overall prediction of the yearly number of 
congenitally infected infants in the total population. In addition, the high preva- 
lence of congenital toxoplasmosis in France and the excess risk encountered by 
young migrant women from lower prevalence areas were confirmed by the model. 
The model might therefore be useful for public health purposes in other countries. 
1986;123:154-61. 
models, theoretical; toxoplasmosis 
The main problem with toxoplasmosis is' 
primary infection (1) during pregnancy. In 
France, prevention of toxoplasmosis is 
based on serum antibody determination. In 
1978, this test was required for any woman 
attending the mandatory prenuptial medi- 
cal examination (Decree no. 78-396, March 
17, 1978). Furthermore, obstetricians are 
strongly advised to  perform the serologic 
surveillance of any nonimmune pregnant 
woman. Although widely applied, such 
measures do not allow the assessment of 
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the seroconversion rate on a national level, 
Because data are not centralized. Only 
crude prevalence rates of seropositive tests 
are provided by regional laboratory centers. 
The figures, ranging from 40 per cent to 80 
per cent, and even more in the Parisian 
area, are mentioned as among the highest 
in the world (1). Some useful information 
was obtained in studies conducted in ma- 
ternity hospitals (2, 3). According to the 
various sources, the proportion of acquired 
toxoplasmosis among pregnant women 
would be from 0.5 per cent to 1 per cent. 
About half of the offsprings are affected in 
the absence of treatment. In the Desmonts 
and Couvreur study (3), short-term compli- 
cations were observed in 14 per cent of the 
children and death in 6 per cent. In spite 
of the lack of exhaustive and accurate data, 
it is clear from these figures that acquired 
toxoplasmosis is particularly frequent in 
France, compared with other countries, 
such as Norway (4) and the United States 
(5), where only 12 per cent and 30 per cent, 
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respective]), (A' the women are reported 
"positive" at childbearing age. 
Such a high risk of congenital infection 
represents a significant public health prob- 
lem; as a consequence. it is necessary to 
assess the actual impact of the disease, in 
ternis of expected number of primary infec- 
tions in one year. The ilse of mathematical 
model:, for description and prediction pur- 
poser: has already been the occasion for a 
numhcr of publications, especially for ru- 
bella, herpes simplex, varinla. measles. and 
soine other cnmmunicnble diseases (6). To 
oiir knowledge, very few authors have pm- 
posed a model tn study the endemicity ot 
tnxnplasiiirisis, still one of the most fre- 
quent cnngenital inf'ertinnx. Some theoretic 
curves resulting frnm a simul a t' inn were 
shown in the comprehensive review by 
Frenkel in 197.1 (71. 
To reinforce the preventive action initi- 
ated in 1978, in 1982-1983 the French Min- 
istry nf Health decided ro carry out a na- 
tional seroepidemiolngic survey amnng 
wnmen of childbearing age. The importance 
of the prevalence data prnvided by age of - 
fered the opportunity tn test the adequacy 
of' FI probability model. as dexrihed belnw. 
 ETHO HOD^ 
Tht? I H O ~ Q I  
The model iised i.: bawd nn the following 
single hspothesih: Each individual in n 
tilatinn i h  submitted to a risk ( r )  
the prohability of contact with 
T~r.u~pltr.sn~o g ntlii during trne >ear. The 
ri& is onl\ related tn environment and 
therefore is the same for all subjects. and 
identic*al inr each year oi life. frnni hirth to 
death. SeriIconvcr4on occurs at the drst 
cnntart. Thiih, r cmrespnndb to  the hero- 
rnnversinn rat e or inridenc*e rate. 
Let P,  be the probability of being sero- 
pnsitiLe at age .Y ¡.I in years) and Qr = 1 - 
P,  the prohahility of being sernnegative at 
age .Y in the sanie pijpulation. Thus, 
P ,  = r ( I  - r1l-I ( 1 )  
r 
, = 1  
Zilld 
qy = ( 1  - rl'. ( 2 )  
The basic equations and the connected 
hypotheses can be found in Lilienfeld's 
handbook of epidemiology (8). It appears 
that r can be theoretically estimated if one 
knows the prevalence of serum Toxopl~nza  
antibodies in a group of subjects born the 
same year and living in the same country 
since hirt h. 
It follows from equation 2 that the risk 
of primary infection during pregnancy be- 
tween age -Y and Y' will be 
R,, = O.'ï5 (1 - r)' 
T 
1=r+1 
r (1  - r)f-T-l  g f ,  (3)  
where g1 is the probability nf a wnnian be- 
cciining pregnant at age i among the female 
populatinn of childbearing age. and 0.75 is 
the duration cd gestation in one year. 
Tf a cohort of migrant people move at a 
given age CI ( n  < x and migration is assumed 
to occur on an individual's hir-thday) from 
a country 1 characterized by a risk r1 to 
another country 2 characterized by a risk 
r. equations 1 and 2 must he replaced, 
respectively, hy 
CI I 
P' ,  = c r l ( l  - rl)l-l + 
1-1 1=u41 
r l i l  - rlY' ( 1  - I -~J ' - '~ - '  (41 
and 
Q'x = (1 - r1 lu  ( 1  - rL)'-". (5) 
P i p i  lntion 
Women were recruited who came for hi- 
ologic blnod sample tests in 69 rnedical 
analyses laboratorieh in 11 administrative 
regions in France. Selection referred only 
to age, which was required to he at least 15 
years and below 15 years. Serum samples 
were systematically sent to one laboratory 
where T(ixiip/plasmn antibodies were tested 
by the imniunnfluorescence method (91, un- 
der the responsibility nf one nf the authors 
(H. S. 1. Evidence of previnus infection was 
assessed by a result at least equal to 10 ILI. 
In  the L'ourse of the studh, between No- 
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vember 1982 and April 1983, results were 
obtained from 7,605 women of French ex- 
traction and 680 migrant women. 
The reason for examination was a sys- 
tematic medical visit in 72.5 per cent of the 
cases: prenuptial 2.5 per cent, antenatal 
31.3 per cent, routine check-up 38.7 per 
cent. The remaining 27.5 per cent were 
related to a health problem. 
Statistical methods 
Estimations of r were first calculated di- 
rectly, and the corresponding variances 
were estimated by the 6 method (10). An 
overall estimation was then obtained by the 
maximum likelihood method. The search 
for the zero of t,he likelihood derivative was 
achieved by a dichotomous method (11). 
(Computer routines are available upon re- 
quest to the authors.) The confidence in- 
terval for the maximum likelihood estimate 
was obtained by the asymptomatic normal- 
ity and variance for maximum likelihood 
estimates. The adequacy of the model was 
tested by comparison of observed and ex- 
pected frequencies by the x2 test. Other 
results were obtained by computer simula- 
tion procedures. 
RESULTS 
Testing the model 
This section applies to the data observed 
on women of French extraction. 
Point estimations. According to equation 
2, a series of 30 independent estimates of r 
were obtained from the percentage, q,, of 
seronegative women observed in the 30 age 
( 6) 
and the corresponding approximate vari- 
ance was obtained by the 6 method. 
groups, x, by 
2; = 1 - exp(1og q x / x ) ,  
(7) 
where px  is the proportion of seropositive 
women and n, the size of the age group x. 
The results, ;x, range from 0.027 to 0.051 
(table 1). There is no remaining linear ef- 
fect of age (correlation coefficient = 
0.00008). After weighting according to the 
inverse of the variances .G2pz, a weighted 
average of 0.0369 is found. 
Maximum likelihood. A better estimation 
can be expected using the maximum like- 
lihood method, in which each woman is 
defined by her serologic status (O = nega- 
tive, 1 = positive). At age x = xi, let nio be 
the number of seronegatives and nil the 
number of seropositives. Hence, for i = 1, 
. . . K ,  the logarithmic likelihood is 
L = log(1 - r )  
k 
ni0 xi 
i= 1 
k + nil logil - (1 - r)'']. (8) 
It can be shown that the derivative - is 
close to zero for i. = 0.0375 with a 95 per 
cent confidence interval equal to 0.0364- 
0.0386. When the variability of the preced- 
ing 30 estimates is studied by reference to 
the maximum likelihood estimate, the dis- 
tribution of (;, - 0.O375)/irx appears to be 
approximately normal with mean = 0.12, 
and only three values out of 30 are found 
out of 2 standard deviations from the mean. 
Accordingly, the comparison of the ex- 
pected and observed frequencies within the 
30 age groups provides a x2 value equal to 
33.9, corresponding to a p  value of about 22 
per cent (table 1). Thus, it can be consid- 
ered that the model is acceptable. The fol- 
lowing results were established using the 
number provided by the maximum like- 
lihood method. 
ì=l 
dL 
dr 
Using the model 
Prediction of congenital infections. Once 
an estimation of r and the age distribution 
of the pregnant women in the general pop- 
ulation are available, it is possible to ap- 
proach the annual number of primary in- 
fections by Toxoplasma during pregnancy. 
The proportions, g,, of pregnancies among 
women of age x between ages 15 and 44 
years were replaced in equation 3 according 
to the French national statistics (12). The 
Ohserved no. Expected no. 
5 of 
NIL c d w m c r i  negative Estirnate vf r 
(Y*) 
s -,. Ag? 
of negative I \ (  111-61 of negative 
i r1 ,e t  I 'I," f i l , , )  women I r, 1 
Ir1 
I yars  I 
4Ssi 
43.9 
48.7 
40.7 
46.9 
42.6 
49.S 
41.6 
3!l.ti 
42.2 
41.n 
37.G 
475  
:i5.6 
:ilkì 
32.5 
24.v 
25.1 
??i2 
29.6 
"4.4 
l:.:ì 
31.7 
21.7 
14.5 
12.1 
16.7 
19.1 
21.4 
70.2 
28.5 
1fi.d 
13.2 
8.n 
8.2 
s.11 
ti.1 
5.9 
5.3 
s.1 
5.2 
:ì.ti 
5.9 
til 
6.6 
111.2 
111.7 
!).Il 
8.9 
1 11.8 
22.b 
3ii.iI 
11ì.1 
".fi 
42.5 
:it:. 1 
2% 
21.1 
ï.n 
38.3 
71.0 
lil3.$1 
123.6 
156.7 
176.i) 
194.*5 
1t)lI.ti 
186.iC 
166.2 
163.2 
1:3$4.:3 
123.4 
101.6 
99.4 
91.4 
85.6 
66.1; 
61.9 
.i:j.:i 
51.8 
:i:ì.s 
"63  
25.9 
"5.4 
l!UI 
113 
15.2 
15.6 
xn.4 
estimated niinihers of maternal semcnnver- 
eions h y  age are shown in table 2: the 
absolute and relative distributinns of the 
risk are repre\ented in t5gure 1. Globally, a 
figure a+ high as nearly 8,600 ( 1.06 per cent) 
acquired T f ~ . t ( ~ p h r ~ ? n  infections may be es- 
pected each year. I n  total absence of inter- 
vention, it might result in inore than 5.000 
cases i 6.411,OOO 1 ni congenital tosoplas- 
niois arnong the offsprings, on the hasis of 
an incidence rate equal to 60 per cent. as 
reported by D~'snicint~ and Couvreur (fi). 
I r i t e r ~ ~ n p c i l a t i o r r  diffcrt:riccb It would be 
of great interest tn  predict the rate nf nia- 
terna1 infe'ertion in different popillatinns ac- 
cnrding tn the cwrrespnnding serr)conver- 
4 0 t 1  ritte+. Eqiiation 8 clearly indicbates that 
R ,  i\ curiilinear and passes through a 
mn-iirniiin fnr n given value of r. Untiirtu- 
nately. it was impns4hle to assess the in- 
terpopulation relatinnship mathematically, 
since the maternal infection rate depends 
on the age distribution among pregnant 
w m e n  in each country. Thus, we used the 
French data gr to obtain by a himulatinn 
procedure the values of RA.r for Y = 15 years 
and Y '  = 44 years according to values nf r 
ranging frnni 0 per cent to  20 per cent. I t  is 
nbserved thnt the percentage of maternal 
infections increases up to 1.07 per cent fnr 
r = 0.038 and decreases thereafter. sn that 
the previous estimate of' r in the French 
popidatinn is close to the highest possible 
risk for pregnant women (fibgire 2).  It is 
important to note that two values of r as 
diff'erent as 0.01 and 0.098 lead to the same 
risk (0.6 per cent). 
ilíicrant z i " m w .  I-nung women moving 
158 PAPOZ ET AL. 
TABLE 3 
Expected risk of acquired toxoplasmosis during 
pregnancy, according to age 
Sno of acquired :z P r ~ ~ ~ ~ ~ o f  toxoplasinosist NO. of 
during seroconverters 
pregnancy (years) women* 
15 0.3 
16 1.2 
17 3.8 
18 8.6 
19 16.8 
20 26.5 
21 36.3 
22 45.1 ~~ 
23 51.9 
24 57.0 
25 58.7 
26 58.2 
27 55.0 
28 49.7 
29 45.1 
30 39.5 
31 34.7 
32 28.6 
33 23.8 
34 19.1 
35 14.5 
36 9.1 
37 7.2 
38 5.3 
39 3.6 
40 2.5 
41 2.0 
43 1.2 
43 0.8 
44 0.4 
Total 706.5 
1.65 
1.58 
1.53 
1.47 
1.41 
1.36 
1.31 
1.26 
1.21 
1.17 
1.12 
1.08 
1.04 
1.00 
0.96 
0.93 
0.89 
0.86 
0.83 
0.80 
0.77 
0.73 
0.72 
0.68 
0.65 
0.64 
0.61 
0.58 
0.57 
0.54 
1.06 
5 
22 
66 
143 
271 
41 1 
541 
648 
718 
758 
751 
717 
652 
567 
496 
417 
353 
280 
224 
174 
127 
76 
59 
41 
27 
18 
14 
8 
5 
3 
8,592 
* Number of pregnant women aged x years per 10,000 out 
of the total female population aged 15-44 years, according to 
French national statistics. 
t Expected percentage of acquired toxoplasmosis (calcu- 
lated according to the proposed model) among the total num- 
ber of pregnancies observed in a year. 
from a country of low prevalence to a coun- 
try of high prevalence are exposed to an 
increased risk of primary infection during 
pregnancy. For instance, figure 3 shows the 
cumulative percentage of seropositive 
women among a cohort having moved at  
age 15 years from a country where r = 0.01 
to  a country where r = 0.037. The incre- 
ment of prevalence between ages 15 and 44 
years is then more than 57 per cent instead 
of 36 per cent. In the screened sample, the 
prevalence rates were found markedly 
lower among migrant women (globally, 58 
per cent) compared with the French women 
(globally, 67 per cent). 
DISCUSSION 
In the first part of the results, it is estab- 
lished that the model adequately describes 
epidemiologic data. This is consistent with 
a body of evidence from numerous studies 
(7, 13) showing that within a given popu- 
lation, age is not only the main variate 
related to Toxoplasma infection but ac- 
counts for nearly all the differences be- 
tween groups. This means that the duration 
of exposure is sufficient to describe the 
phenomenon in a given population, in spite 
of the possible variations over space and 
time of the complex underlying factors 
leading to seroconversion. The points to 
discuss are the degree of representativeness 
of the studied sample and the reliability of 
the serologic test used. As a matter of fact, 
the subjects were included consecutively 
during a given period and not randomly 
selected among the whole population. Re- 
gardless of the fact that a random selection 
method, although highly desirable, would 
raise serious difficulties, it may be under- 
lined that the size of the age groups was 
taken into account in the calculations. In 
addition, the prevalence rates compared ac- 
cording to socioeconomic status or to the 
reason for a biologic test prescription did 
not show any marked difference. 
On the other hand, it cannot be rejected 
that a serologic test using the immunoflu- 
orescence method could be less sensitive 
than the dye test and therefore may pro- 
duce less positive results. In this study, we 
obtained lower percentages of seropositive 
women than did Desmonts et al. (14) 20 
years ago in a large prospective survey. The 
origin of the population under screening, 
however, was restricted to the Parisian 
area, where the risk of contamination is 
particularly high (because undercooked 
meat is more often consumed (15)), 
whereas the present study is a national one. 
Moreover, it is likely that the spread of 
toxoplasmosis has changed over time with 
the improvement of hygiene standards, the 
decreasing number of stray cats, the use of 
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FIGURE 1. Expected risk of acquired toxoplasniohi~ (A.T.) during pregnancy from ages 15 to  44 years. The 
decreasing ciirle corresponds to  the ahwlutc risk and the dfitted line to the calculated age-related distrihution 
nf acquired tnroplawiiisih. For instarice, for any 98-year-old woman hecnming pregnant, the risk is equal tn 1 
per cerit, while 6.6 per cent of the tntal cases of acquired toxoplasmosis occur in this age grnup. 
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FIGIIRF 2. Expected maternal infection rate R,, (per w i t  J tin .Y = 15 !'ears and 1' = 14 y e a n  according to 
the seroronversion rate r (per cent 1 in the French popdation aged 15--14 years. A maximum value of 1.Oí per 
cent is cd~tztinrd for r = 3.8 per cent. 
canned diet:: for domestic animals, and of 
frozen food for humans. 
In the second part of the results, the 
model was used to predict the number of 
Tnsr7plnsma infections during pregnancy. 
We found a rate of a h u t  1.0 seroconver- 
sions in 1.000 pregnancies, a figyre which 
is finally consistent with the data reported 
in previous studies: According to the num- 
ber of seroconverters observed in diff'erent 
samples by Desnionts et al. (14)  and Des- 
monts and Couvreur (161, the rate lies he- 
tween four and 12 maternal infections per 
1,000 pregnancies. More recently, Lapierre 
et al. (l'i) followed 15,132 pregnant women 
from 1977 to  1982 in another Parisian cen- 
ter and found a rate of 5.35 maternal infec- 
tions per 1,000 pregnancies. It must be kept 
in mind that these figires were calculated 
on crude data obtained under routine con- 
ditions, wit hout taking age into account or 
evaluating the proportion of drop-out sub- 
jects. Thus, the theoretic estimation 
methnd used here is probably relevant to 
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FIGURE 3. Calculated cumulative prevalence rate 
P', (per cent) according to age x up to 45 years in a 
cohort of migrant women having moved a t  age 15 from 
a country where the seroconversion rate ( r )  is equal 
to 1 per cent to a country where r = 3.7 per cent. The 
lower curve represents the cumulative prevalence rate 
P, corresponding to r = 1 per cent in the absence of 
migration, according to equation 1 (see text). The 
upper curve represents the cumulative prevalence rate 
P' after migration, according to equation 4 (see text). 
the actual impact of toxoplasmosis on pub- 
lic health and can be applied in any popu- 
lation. Reliable comparisons could then be 
undertaken, in order to understand, for in- 
stance, the mechanisms leading to wide 
differences in the seroconversion rate in 
similar countries. 
The equations derived from the model 
provided a mathematical description for a 
number of things that were previously ob- 
served in different studies. Equation 3 
showed that exposure to Toxoplasma infec- 
tion for pregnant women is maximum for 
an intermediate value of the seroconversion 
rate, r. According to the estimate of r, we 
found that the exposure was close to the 
maximum for pregnant women in the 
French population. Simultaneously, this 
explains why the risk may be identical in 
countries of low and high prevalence, as 
already mentioned (4, 7). When equation 4 
is used, it is possible to  assess quantita- 
tively the increased risk of seroconversion 
for people coming from a country of low 
prevalence to a country of high prevalence, 
a phenomenon which deserves the consid- 
eration of the public health services. 
In any kind of population, similar infor- 
mation may be derived from serologic data 
by age groups. Unfortunately, the data 
available from other countries that we used 
were not sufficiently documented regarding 
age to allow their analysis by our method. 
It is essential that the age groups should be 
of one year and preferably of equal size. If 
this is so, the adequacy of the model can be 
first verified using equation 2 in a few well 
chosen age groups, for example 15,25, and 
35 years. The subsequent calculations are 
easy to achieve with the help of a micro- 
computer. Then, the prevalence rates at  
any age or the increment of prevalence over 
an age interval can be estimated with a 
minimal data set collection. This is the 
main interest of the model, facing the lack 
of hard data concerning toxoplasmosis in 
almost all countries, while the use of rele- 
vant information is the necessary first step 
for any efficient policy of prevention (18). 
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